Aspen Pharmacare – is the market rating the share price too low? Read the long-term Mergence houseview by Portfolio Manager Izak van Niekerk.
Rand resilience masks a fragile equilibrium
The rand’s recent resilience has surprised many, but it risks being misread. Strength in the currency over the past year
